Recent studies have indicated that KRAS plays a key role in coordinating tumor metabolic reprogramming by upregulating the transcription of multiple key glycolysis enzymes, such as HK1/2, PFK1, LDHA, and GLUT1. This evidence concerns the gene PFKM and neoplasm.